BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30799622)

  • 1. Identification of C-6 as a New Site for Linker Conjugation to the Taccalonolide Microtubule Stabilizers.
    Du L; Risinger AL; Yee SS; Ola ARB; Zammiello CL; Cichewicz RH; Mooberry SL
    J Nat Prod; 2019 Mar; 82(3):583-588. PubMed ID: 30799622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taccalonolide microtubule stabilizers.
    Li J; Risinger AL; Mooberry SL
    Bioorg Med Chem; 2014 Sep; 22(18):5091-6. PubMed ID: 24491636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Taccalonolide Microtubule Stabilizers.
    Yee SS; Du L; Risinger AL
    Prog Chem Org Nat Prod; 2020; 112():183-206. PubMed ID: 33306174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent taccalonolides, AF and AJ, inform significant structure-activity relationships and tubulin as the binding site of these microtubule stabilizers.
    Li J; Risinger AL; Peng J; Chen Z; Hu L; Mooberry SL
    J Am Chem Soc; 2011 Nov; 133(47):19064-7. PubMed ID: 22040100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular studies reveal mechanistic differences between taccalonolide A and paclitaxel.
    Risinger AL; Mooberry SL
    Cell Cycle; 2011 Jul; 10(13):2162-71. PubMed ID: 21597323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taccalonolide C-6 Analogues, Including Paclitaxel Hybrids, Demonstrate Improved Microtubule Polymerizing Activities.
    Risinger AL; Hastings SD; Du L
    J Nat Prod; 2021 Jun; 84(6):1799-1805. PubMed ID: 34110822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrolysis reactions of the taccalonolides reveal structure-activity relationships.
    Li J; Peng J; Risinger AL; Mooberry SL
    J Nat Prod; 2013 Jul; 76(7):1369-75. PubMed ID: 23855953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taccalonolide binding to tubulin imparts microtubule stability and potent in vivo activity.
    Risinger AL; Li J; Bennett MJ; Rohena CC; Peng J; Schriemer DC; Mooberry SL
    Cancer Res; 2013 Nov; 73(22):6780-92. PubMed ID: 24048820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and biological activities of new taccalonolide microtubule stabilizers.
    Peng J; Risinger AL; Fest GA; Jackson EM; Helms G; Polin LA; Mooberry SL
    J Med Chem; 2011 Sep; 54(17):6117-24. PubMed ID: 21800839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taccalonolides E and A: Plant-derived steroids with microtubule-stabilizing activity.
    Tinley TL; Randall-Hlubek DA; Leal RM; Jackson EM; Cessac JW; Quada JC; Hemscheidt TK; Mooberry SL
    Cancer Res; 2003 Jun; 63(12):3211-20. PubMed ID: 12810650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic Analysis and in Vivo Antitumor Efficacy of Taccalonolides AF and AJ.
    Risinger AL; Li J; Du L; Benavides R; Robles AJ; Cichewicz RH; Kuhn JG; Mooberry SL
    J Nat Prod; 2017 Feb; 80(2):409-414. PubMed ID: 28112516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic reactions with rare taccalonolides reveal the value of C-22,23 epoxidation for microtubule stabilizing potency.
    Peng J; Risinger AL; Li J; Mooberry SL
    J Med Chem; 2014 Jul; 57(14):6141-9. PubMed ID: 24959756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taccalonolides: Novel microtubule stabilizers with clinical potential.
    Risinger AL; Mooberry SL
    Cancer Lett; 2010 May; 291(1):14-9. PubMed ID: 19880245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidating target specificity of the taccalonolide covalent microtubule stabilizers employing a combinatorial chemical approach.
    Du L; Yee SS; Ramachandran K; Risinger AL
    Nat Commun; 2020 Jan; 11(1):654. PubMed ID: 32005831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a Covalent Microtubule Stabilizer in Taxane-Resistant Ovarian Cancer Models.
    Yee SS; Risinger AL
    Molecules; 2021 Jul; 26(13):. PubMed ID: 34279417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taccalonolide Microtubule Stabilizers Generated Using Semisynthesis Define the Effects of Mono Acyloxy Moieties at C-7 or C-15 and Disubstitutions at C-7 and C-25.
    Ola ARB; Risinger AL; Du L; Zammiello CL; Peng J; Cichewicz RH; Mooberry SL
    J Nat Prod; 2018 Mar; 81(3):579-593. PubMed ID: 29360362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The taccalonolides and paclitaxel cause distinct effects on microtubule dynamics and aster formation.
    Risinger AL; Riffle SM; Lopus M; Jordan MA; Wilson L; Mooberry SL
    Mol Cancer; 2014 Feb; 13():41. PubMed ID: 24576146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of microtubule stabilization by taccalonolide AJ.
    Wang Y; Yu Y; Li GB; Li SA; Wu C; Gigant B; Qin W; Chen H; Wu Y; Chen Q; Yang J
    Nat Commun; 2017 Jun; 8():15787. PubMed ID: 28585532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemically diverse microtubule stabilizing agents initiate distinct mitotic defects and dysregulated expression of key mitotic kinases.
    Rohena CC; Peng J; Johnson TA; Crews P; Mooberry SL
    Biochem Pharmacol; 2013 Apr; 85(8):1104-14. PubMed ID: 23399639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The taccalonolides, novel microtubule stabilizers, and γ-radiation have additive effects on cellular viability.
    Risinger AL; Natarajan M; Thomas CR; Mooberry SL
    Cancer Lett; 2011 Aug; 307(1):104-111. PubMed ID: 21507571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.